Closed Formulary Systems

Closed Formulary Systems is a pharmaceutical reimbursement policy framework that restricts coverage to a specified list of medications, excluding non-listed agents unless granted exceptions through formal review processes.

5

Publications

179

Citations

8

Authors

3

Institutions

Publications per year

2017–2026

0

Authors

8

  1. RW
    Robert W. Hammel

    University of Wisconsin–Madison, United States

    2 publications · 30 citations

    2

    h-index

  2. BR
    Brenda R. Motheral

    Express Scripts Holding Company (United States), United States

    1 publications · 26 citations

    1

    h-index

  3. JJ
    Jake Jacobs

    Palo Alto Institute, United States

    1 publications · 57 citations

    1

    h-index

  4. AM
    Arnold M. Epstein

    Harvard University, United States

    1 publications · 66 citations

    1

    h-index

  5. HA
    Haiden A. Huskamp

    Harvard University, United States

    1 publications · 66 citations

    1

    h-index

1–5 of 8

Institutions

3

  1. Express Scripts Holding Company (United States)

    St Louis, United States

    1 h-index

    1 publications

    26 citations

  2. Harvard University

    Cambridge, United States

    1 h-index

    1 publications

    66 citations

  3. University of Pennsylvania

    Philadelphia, United States

    1 h-index

    1 publications

    57 citations

1–3 of 3

Venues

  1. JAMA

    2 publications · 30 citations

    2

    h-index

  2. Medical Care

    1 publications · 57 citations

    1

    h-index

  3. American Journal of Health-System Pharmacy

    AJHP · 1 publications · 26 citations

    1

    h-index

  4. Health Affairs

    1 publications · 66 citations

    1

    h-index

1–4